| Trial ID: | L5422 |
| Source ID: | NCT00629213
|
| Associated Drug: |
Acarbose
|
| Title: |
Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Metabolic Syndrome
|
| Interventions: |
DRUG: acarbose|DRUG: placebo
|
| Outcome Measures: |
Primary: Incidence of newly diagnosed type 2 diabetes | Secondary: newly diagnosed hypertension
|
| Sponsor/Collaborators: |
Sponsor: GWT-TUD GmbH
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
1429
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2008-03-07
|
| Locations: |
GWT-TUD GmbH, Dresden, Saxony, 01187, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00629213
|
